Status:
COMPLETED
Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
Lead Sponsor:
Allergan
Conditions:
Retinal Vein Occlusion
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective data collection study to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular edema due to RVO. Following informed consent, there we...
Eligibility Criteria
Inclusion
- Macular edema
- Received at least 2 OZURDEX® injections
Exclusion
- Received OZURDEX® injections as part of a clinical study
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT01411696
Start Date
July 1 2011
End Date
March 1 2012
Last Update
April 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Antonio, Texas, United States